Endologix endures FDA deadly warning over recall

Endologix recalled its AFX Introducer System back in May, and now the FDA has assigned its most serious warning to the catheter-insertion device, saying it could cause serious injury or death. The company launched the recall in response to reports that the device's dilator could break during implantation procedures, asking customers to cease using and distributing the product, and the FDA has designated the recall a Class I, used only when products put patients at serious risk. More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.